2017
DOI: 10.5935/1676-2444.20170061
|View full text |Cite
|
Sign up to set email alerts
|

Pseudothrombocytopenia: incidence and strategy for resolution in clinical laboratory

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…None of the mentioned guidelines describe how to quantify aggregation, and not all guidelines have a precise definition of aggregation. Accordingly, previous studies of PTCP from hematology instruments have used various or unspecified definitions of aggregation, raising the concern that the studies may not be comparable 6–10 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…None of the mentioned guidelines describe how to quantify aggregation, and not all guidelines have a precise definition of aggregation. Accordingly, previous studies of PTCP from hematology instruments have used various or unspecified definitions of aggregation, raising the concern that the studies may not be comparable 6–10 …”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, previous studies of PTCP from hematology instruments have used various or unspecified definitions of aggregation, raising the concern that the studies may not be comparable. [6][7][8][9][10] The aim of this study was to investigate the diagnostic accuracy of the flag PLT-Clumps from the WNR/WDF and the PLT-F channels from Sysmex XN. Furthermore, we aimed to study how different cutoffs for investigation for PTCP and different definitions of platelet aggregation affected the diagnostic accuracy.…”
mentioning
confidence: 99%
“…In most European countries, the most common formulation used is K2EDTA. EDTAdependent pseudothrombocytopenia (EDTA-PTCP) is caused by EDTA-depentent antiplatelet IgM and IgG antibodies which recognize cytoadhesive glycoprotein IIb/IIIa receptors on the platelet plasma membrane, and it occurs at room temparature (2). EDTA-PTCP is a rare phenomenon with overall prevalence of 0.1% in the general population and is not sex-or age-dependent.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with infection, autoimmune diseases and malignancy might have an increased risk of EDTA-PTCP. However, it was recorded in a disease-free population as well (2,3). This phenomenon ocurrs only in vitro and is solely a laboratory artifact because with a different antico-agulant used, the patient presented the physiological platelet count (4).…”
Section: Introductionmentioning
confidence: 99%